Clinical trial
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
NCT00323817 · Zeria Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00323817 |
|---|---|
| Title | To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia |
| Lead sponsor | Zeria Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Functional Dyspepsia |
| Intervention type | Drug |
| Interventions | Z-338 |
| Enrollment | 282 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | May 10, 2006 |
| Last update posted | May 28, 2015 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: